CD14, a pattern recognition receptor found on myeloid cells, is a critical
component of the innate immune system that mediates local and systemic host
responses to Gram-negative and Gram-positive bacterial products. Previous
studies in normal animals have tested the effect of CD14 blockade on the sy
stemic response to i.v. LPS. The goals of the study were to determine wheth
er CD14 blockade protected against the deleterious systemic response associ
ated with Escherichia coli pneumonia and to determine whether this strategy
affected the pulmonary response to tissue infection. Rabbits were pretreat
ed,vith either anti-CDI4 mAb or isotype control mAb at 2.5 mg/kg. E. coli (
1 x 10(9) CFU) was inoculated into the lungs, and the animals were observed
for either 4 or 24 h, The blockade of CD14 improved the mean arterial bloo
d pressure (p = 0.001) and decreased the i.v. fluid requirements (p = 0.01)
. Although this therapy protected the vascular compartment, rabbits treated
,vith anti-CD14 mAb had increased bacterial burdens in the bronchoalveolar
lavage fluid recovered from the instilled lung (p = 0.005) and widened alve
olar-arterial oxygen difference. Blockade of CD14 prevents the deleterious
systemic responses that occur in sepsis; however, other measures are necess
ary to control bacterial proliferation at the primary site of infection.